Top-News

Rock Creek Pharmaceuticals News

Aktie
WKN:  A14RTV ISIN:  US7720812046 US-Symbol:  RCPIQ
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
170,44 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 15.05.2018

Rock Creek Pharmaceuticals News

11.08.16 - PR Newswire
Rock Creek Pharmaceuticals Provides Corporate Update and Announces 2016 Second Quarter Results
Rock Creek Pharmaceuticals Provides Corporate Update and Announces 2016 Second Quarter Results PR Newswire
08.07.16 - PR Newswire
Rock Creek Pharmaceuticals Announces Interim Amendments to Convertible Notes and Update on Financing Options
Rock Creek Pharmaceuticals Announces Interim Amendments to Convertible Notes and Update on Financing Options PR Newswire
08.07.16 - PR Newswire
Rock Creek Pharmaceuticals Announces Interim Amendments to Convertible Notes and Update on Financing Options
Rock Creek Pharmaceuticals Announces Interim Amendments to Convertible Notes and Update on Financing Options PR Newswire
01.06.16 - PR Newswire
Rock Creek Pharmaceuticals to Present at the 2016 BIO International Convention and the LD Micro Invitational Conference
Rock Creek Pharmaceuticals to Present at the 2016 BIO International Convention and the LD Micro Invitational Conference PR Newswire
16.05.16 - PR Newswire
Rock Creek Pharmaceuticals Provides Clinical Update and Announces 2016 First Quarter Results
Rock Creek Pharmaceuticals Provides Clinical Update and Announces 2016 First Quarter Results PR Newswire
16.05.16 - PR Newswire
Rock Creek Pharmaceuticals Provides Clinical Update and Announces 2016 First Quarter Results
Rock Creek Pharmaceuticals Provides Clinical Update and Announces 2016 First Quarter Results PR Newswire
05.05.16 - PR Newswire
Rock Creek Pharmaceuticals Announces Japanese, European and U.S. Patent Developments and Valuation Initiative for Lead Compound
Rock Creek Pharmaceuticals Announces Japanese, European and U.S. Patent Developments and Valuation Initiative for Lead Compound PR Newswire
05.05.16 - PR Newswire
Rock Creek Pharmaceuticals Announces Japanese, European and U.S. Patent Developments and Valuation Initiative for Lead Compound
Rock Creek Pharmaceuticals Announces Japanese, European and U.S. Patent Developments and Valuation Initiative for Lead Compound PR Newswire
22.03.16 - PR Newswire
Rock Creek Pharmaceuticals Announces 2015 Annual Results and Provides Commentary and Review
Rock Creek Pharmaceuticals Announces 2015 Annual Results and Provides Commentary and Review PR Newswire
22.03.16 - PR Newswire
Rock Creek Pharmaceuticals Announces 2015 Annual Results and Provides Commentary and Review
Rock Creek Pharmaceuticals Announces 2015 Annual Results and Provides Commentary and Review PR Newswire
01.03.16 - PR Newswire
Rock Creek Pharmaceuticals Announces the Addition of Distinguished Dermatologist as a Scientific Advisor
Rock Creek Pharmaceuticals Announces the Addition of Distinguished Dermatologist as a Scientific Advisor PR Newswire
01.03.16 - PR Newswire
Rock Creek Pharmaceuticals Announces the Addition of Distinguished Dermatologist as a Scientific Advisor
Rock Creek Pharmaceuticals Announces the Addition of Distinguished Dermatologist as a Scientific Advisor PR Newswire
03.02.16 - PR Newswire
Rock Creek Pharmaceuticals Announces Inhibition of STAT 3 Activation, A Key Marker of Inflammation, In Phase I Clinical Trial in Europe
Rock Creek Pharmaceuticals Announces Inhibition of STAT 3 Activation, A Key Marker of Inflammation, In Phase I Clinical Trial in Europe PR Newswire
05.01.16 - PR Newswire
Rock Creek Pharmaceuticals Presentation at Biotech Showcase 2016 to be Webcast
Rock Creek Pharmaceuticals Presentation at Biotech Showcase 2016 to be Webcast Web Link Provided Below PR Newswire
05.01.16 - PR Newswire
Rock Creek Pharmaceuticals Presentation at Biotech Showcase 2016 to be Webcast
Rock Creek Pharmaceuticals Presentation at Biotech Showcase 2016 to be Webcast PR Newswire
10.12.15 - PR Newswire
Rock Creek Pharmaceuticals to Present at Biotech Showcase 2016
Rock Creek Pharmaceuticals to Present at Biotech Showcase 2016 PR Newswire
03.12.15 - PR Newswire
Rock Creek Pharmaceuticals Announces the Addition of Key Opinion Leaders to Enhance Dermatological Disease Program
Rock Creek Pharmaceuticals Announces the Addition of Key Opinion Leaders to Enhance Dermatological Disease Program PR Newswire
03.12.15 - PR Newswire
Rock Creek Pharmaceuticals Announces the Addition of Key Opinion Leaders to Enhance Dermatological Disease Program
Rock Creek Pharmaceuticals Announces the Addition of Key Opinion Leaders to Enhance Dermatological Disease Program PR Newswire
19.11.15 - PR Newswire
Rock Creek Pharmaceuticals Appoints New Director
Rock Creek Pharmaceuticals Appoints New Director PR Newswire
19.11.15 - PR Newswire
Rock Creek Pharmaceuticals Appoints New Director
Rock Creek Pharmaceuticals Appoints New Director PR Newswire

Newssuche

Videos

07.05.24 +16,95%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »